Genesis - a Phase III Randomized Double-Blind, Placebo-Controlled, Multi-Center Trial Evaluating the Safety and Efficacy of BL-8040 and G-CSF in Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma – Lead-in Period Results